The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults Notified -
Breaking the speed limit: Wood Mackenzie warns AI data centre power race threatens projects and consumers Notified -
Surge in EHS+ Platform Adoption Among Companies with Leaner Operations Signals Broader Market Shift, Cority Reports Notified -
Constellation Brands Announces Election of Morgan Flatley as New Independent Board Director Notified -
EIF commits EUR 200 million to Copenhagen Infrastructure Partners to scale European biogas production Notified -
Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma Notified -
Qiang Cai and Ricardo Andre Galendi Junior win the 12th IBFD Frans Vanistendael Award for International Tax Law Notified -
Bitget Kicks Off Second Year Supporting UNICEF's Game Changers Coalition, Backing Expansion into Financial Literacy and AI Notified -
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia Notified -
